Canadian Securities Exchange Welcomes Listing of TempraMed Technologies Ltd.

Executive Summary

• TempraMed Technologies Ltd. completed a C$7.4 million private placement, issuing approximately 51.7 million common shares.
• The newly issued shares were listed on the Canadian Securities Exchange (CSE) under ticker VIVI on the same day.
• The listing provides TempraMed with broader investor access and growth capital to scale its temperature‑controlled medication storage solutions globally.

Key Details

• Private placement raised C$7.4 million in gross proceeds.
• Approximately 51.7 million common shares were issued in the private placement.
• Shares began trading on the CSE under ticker symbol VIVI as of October 15, 2025.
• TempraMed focuses on battery‑free, 24/7 temperature‑controlled medication storage devices for pharmacies and healthcare providers.
• CEO Ron Nagar highlighted that public listing “provides access to a broader community of investors and valuable growth capital… the fuel we need to accelerate global scale.”

Notable Quotes

“TempraMed's solutions have the potential to significantly help both pharmacies and their customers,” said James Black, Vice President, Listings Development, CSE.

“Today's listing on the Canadian Securities Exchange marks an exciting new chapter in TempraMed's journey… Going public provides access to a broader community of investors and valuable growth capital.” – Ron Nagar, Founder & CEO, TempraMed.